D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 51,800
-1,700 (-3.18%)
Sep 1, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.37 trillion as of September 1, 2026. Its market cap has increased by 39.41% in one year.
Market Cap
2.37T
Enterprise Value
2.34T
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
51,800.00
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.37T, an increase of 525.56%. That is a compound annual growth rate of 119.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.37T | -40.59% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.84T |
| HLB Co., Ltd. | 4.73T |
| Peptron | 4.27T |
| ABL Bio | 4.07T |
| LigaChem Biosciences | 3.56T |
| SK bioscience | 3.06T |
| Voronoi | 2.97T |
| Hugel | 2.72T |